1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. XERIS BIOPHARMA HOLDINGS INC
Xeris Biopharma Holdings Inc
XNAS: XERS

Xeris Biopharma Holdings Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of...

Read More
6.23 -0.11 (-1.74%)
38.19% Fall from 52W High
1.4M
XNAS Volume

XNAS 05 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Xeris Biopharma Holdings Inc is on 08 May 2026 for the purpose of Xeris Biopharma Holdings Inc First Quarter Earnings Results for 2026 See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Mid Valuation
32.8 / 100
Momentum Score
Technically Neutral
48.9 / 100
Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM
Analyst Price Target
11
1Yr Price target upside is 79%
7 analysts

16

S

11

W

2

O

3

T

SWOT Analysis

Xeris Biopharma Holdings Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..